| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-1656(99)00139-X |
| P8608 | Fatcat ID | release_rv5qo6vbd5cjjj2aucr7cnxai4 |
| P698 | PubMed publication ID | 10486930 |
| P2093 | author name string | Stokes CR | |
| Gruffydd-Jones TJ | |||
| Harbour DA | |||
| Finerty S | |||
| Sturgess CP | |||
| P2860 | cites work | HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women | Q28291024 |
| CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication | Q34390292 | ||
| CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine | Q35621878 | ||
| Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery | Q35868177 | ||
| Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. | Q35877932 | ||
| Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals | Q36806022 | ||
| Protection against vaginal SIV transmission with microencapsulated vaccine | Q38565318 | ||
| Direct ex vivo simian immunodeficiency virus (SIV)-specific cytotoxic activity detected from small intestine intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection | Q39878046 | ||
| A TH1-->TH2 switch is a critical step in the etiology of HIV infection | Q40709038 | ||
| Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells | Q41305656 | ||
| FIV infection of the domestic cat: an animal model for AIDS. | Q41459259 | ||
| Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
| Vaginal and rectal infection of cats with feline immunodeficiency virus | Q43881893 | ||
| Mucosal macrophage subsets of the gut in HIV: decrease in antigen-presenting cell phenotype | Q44219167 | ||
| Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. | Q52062286 | ||
| Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group. | Q53018138 | ||
| Common mechanism of infection by lentiviruses | Q59096936 | ||
| Thein vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant | Q67903115 | ||
| An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status | Q70489799 | ||
| Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques | Q71169973 | ||
| Regulation of mucosal IgA responses in vivo: cytokines and adjuvants | Q71957667 | ||
| HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant | Q72214875 | ||
| Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors | Q72433501 | ||
| P433 | issue | 2-3 | |
| P921 | main subject | feline immunodeficiency virus | Q1129598 |
| P304 | page(s) | 213-221 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Journal of Biotechnology | Q6294860 |
| P1476 | title | Mucosal infection and vaccination against feline immunodeficiency virus | |
| P478 | volume | 73 |
| Q45395136 | Alloimmunity does not protect from challenge with the feline immunodeficiency virus |
| Q34536627 | Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000-2011) |
| Q34529430 | FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review |
| Q45741831 | Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge |
| Q45239329 | Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus. |
| Q33765633 | The variability of serological and molecular diagnosis of feline immunodeficiency virus infection. |
Search more.